Sunday, September 30, 2018

Bacterial therapy tolerable, shows early promise in patients with advanced solid tumors

A phase I clinical trial investigating the use of bacterial Clostridium novyi-NT spores as an injectable monotherapy had manageable toxicities and showed early clinical efficacy in patients with treatment-refractory solid tumor malignancies, according to new data.

from Latest Science News -- ScienceDaily https://ift.tt/2QmSzBG
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Hidden stem cells may be fueling spinal stenosis

Scientists have discovered a stem cell that appears to serve as a master source for tendon and ligament cells throughout the body. In lumbar...